References
- Rosenberg NK, Hougaard E. Cognitive—behavioural group treat-ment of panic disorder and agoraphobia in a psychiatric setting: A naturalistic study of effectiveness. Nord J Psychiatry 2005;59:198–204.
- Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry 1996;57:572–5.
- Zimmerman M, Mattia Ji, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159:469–73.
- Melartin T, Rytsälä H, Leskeld US, Lesteld-Mielonen PS, Sokero P, Isometsä ET. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry 2002;63:126–34.
- Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Frequency and pattern of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry 2004;45:129–37.
- Hirschfeld RM. The comorbidity of major depression and anxiety disorders: Recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001;3:244–54.
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415–28.
- Hotopf M. The pragmatic randomized controlled trial. Adv Psychiatr Treat 2002;8:326–33.